I'm glad I don't have to rely on this fellow's research - quite likely to be an analyst for one of the funds. He certainly likes to rationalise. He omits to mention that those figures from April 2017 relate to the pcp (nine months to March 31 2016) which was NPAT record growth up 145% from the pcp (nine months to March 31 2015). Your credibility is shot. Just be honest.
BKL Price at posting:
$102.02 Sentiment: Buy Disclosure: Held